Form 3 Filing for CalciMedica, Inc.

This filing details the initial ownership of securities by Evgeny Zaytsev, a director at CalciMedica, Inc. (CALC). The securities are held through Bering Partners II, L.P. (Bering II), where Mr. Zaytsev, along with Philip Sawyer, are managing members of the general partner, Bering Partners II GP, L.L.C. (Bering II GP). Mr. Zaytsev may be deemed to have voting and dispositive power over these securities, though beneficial ownership is disclaimed except for any pecuniary interest. The filing includes a warrant exercisable from January 23, 2024, until December 31, 2026, or 30 days after the public disclosure of topline results from the Issuer's Phase 2 clinical trial for acute kidney injury. A notice was given on July 2, 2026, to increase the ownership percentage cap from 4.99% to 19.99%. As of the reporting date, Mr. Zaytsev, through Bering II, holds 2,113,513 shares of common stock and a warrant convertible into 130,651 shares of common stock.